Trial · NCT06302569
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
NCT06302569, Phase 2, Recruiting, Giuseppe Procopio
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma. Trials, record NCT06302569. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06302569
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
- NCT number
- NCT06302569
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 23 participants, estimated
- Lead sponsor
- Giuseppe Procopio
- Conditions
- Bellini Carcinoma, Collecting Duct Carcinoma, Renal Medullary Carcinoma
- Interventions
- Pembrolizumab + Enfortumab Vedotin
- First posted
- 2024-03-08
- Last updated
- 2025-09-09
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ORR in patients treated with Pembrolizumab plus Enfortumab Vedotin | 24 Months | The proportion of patients who have a partial or complete response to Pembrolizumab + Enfortumab Vedotin |
| Secondary | Progression-free survival (PFS) in patients treated with Pembrolizumab plus Enfortumab Vedotin | 24 Months | The time from assignment to Pembrolizumab plus Enfortumab Vedotin to disease progression or death from any cause |
| Secondary | Overall-survival (OS) in patients treated with Pembrolizumab plus Enfortumab Vedotin | 48 Months | Survival from assignment to Pembrolizumab plus Enfortumab Vedotin to time of death. |
| Secondary | Number of Participants treated with Pembrolizumab + Enfortumab Vedotin who experience AEs/SAEs | 24 Months | The incidence of, causality, and outcome of AEs/SAEs. AEs will be assessed as defined by CTCAE, Version \[5.0\]. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers20
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06302569
GET https://conductscience.org/api/trials/v1/NCT06302569/registered